COMBINATION OF ALPHA-7 ACTIVATORS OF NICOTINE ACETYL-CHOLINE RECEPTOR AND ANTAGONISTS mGluR5, INTENDED FOR APPLICATION FOR DOPKINOM-CAUSED DYSKINESIA, ASSOCIATED WITH CAROSTERN DISEASE

摘要

The invention relates to new combinations applicable for the treatment of dyskinesia associated with the treatment of Parkinson's disease with a dopamine agonist, comprising as active ingredients at least one low molecular weight activator of the nicotinic acetylcholine receptor alpha-7 and at least one low molecular weight metabotropic antagonist glutamate receptor 5; to receive them; to their use as medicines and to medicines containing them.